Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial - Salgo, R; Gossmann, J; Schöfer, H (Am J Transplant, 2010)
, et al.